TNF and B-cell non-Hodgkin lymphoma: For instance, lenalidomide (TNF-α inhibitor) and rituximab (anti-CD20 monoclonal antibody) are effective in ABC-DLBCL and CNS lymphoma (CNSL), respectively20, suggestive of a cell-type-specific drug sensitivity in B-cell lymphoma.